Breaking News Bar

Business News and Information

Stocks fight for gains as coronavirus treatment shows promise

A study found Gilead Science's drug remdesivir reduced the risk of death for COVID-19 patients by 62 percent.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear